LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat blood cancers in early trial
Disease control Not yet recruitingThis early-stage study tests a new drug called LY4152199 in about 215 adults with B-cell cancers like lymphoma that have come back or not responded to prior treatment. The drug is designed to help the body's immune cells attack cancer cells. The main goals are to find the safest …
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 04:32 UTC
-
Engineered immune cells take aim at stubborn leukemia
Disease control Not yet recruitingThis early-phase study tests a new treatment for people with certain blood cancers (like acute myeloid leukemia) that have come back or not responded to standard care. Researchers take a patient's own immune cells, modify them in the lab to recognize and attack cancer cells carry…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 15, 2026 11:55 UTC